We are a biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. An estimated 700,000 deaths worldwide each year are attributed to antimicrobial-resistant infections. We intend to address life threatening infections using our therapeutic product candidates from our platform of DLAs, which include lysins and amurin peptides. Lysins are a new class of DLAs which are recombinantly produced antimicrobial proteins with a novel mechanism of action associated with the rapid killing of target bacteria, eradication of biofilms and synergy with conventional antibiotics. Amurin peptides are a novel class of DLAs which exhibit broad-spectrum activity against a wide range of antibiotic-resistant Gram-negative pathogens, including Pseudomonas aeruginosa (P. aeruginosa), Acinetobacter baumannii, and Enterobacter species. We believe that the properties of our lysins and amurin peptides will make them suitable for targeting antibiotic-resistant organisms, such as MRSA and P. aeruginosa, which can cause serious infections such as bacteremia, pneumonia and osteomyelitis. We have completed a Phase 2 clinical trial for the treatment of Staph aureus bacteremia, including endocarditis, with our lead lysin candidate, exebacase, which is the first lysin to enter clinical studies in the U.S. Exebacase, currently being studied in a pivotal Phase 3 clinical study, was granted Breakthrough Therapy designation by the FDA for the treatment of MRSA bloodstream infections, including right-sided endocarditis, when used in addition to SOC anti-staphylococcal antibiotics in adult patients.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 28 Wells Avenue, Yonkers,ny,united States
- Phone
- 9142072300
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- contrafect.com
- HQ
- Yonkers, NY
Contrafect Corp Questions
Contrafect Corp's helpline number is 9142072300
Contrafect Corp's website is contrafect.com
Contrafect Corp's LinkedIn profile is https://www.linkedin.com/company/contrafect-corp
Contrafect Corp has
8 employees.
View email and phone details for 8
employees at Contrafect Corp.
Contrafect Corp's industry is
Biotechnology Research
Contrafect Corp's top competitors are
Phagelux Agrihealth Inc.,
Sapience Therapeutics, Inc.,
Elucida Oncology, Inc.,
Eliava Phage Therapy Center,
Micreos,
Aeglea Biotherapeutics,
Acurx Pharmaceuticals, Inc. (Nasdaq: Acxp),
Genmab,
Biocept, Inc.,
Filament Health.
Contrafect Corp's categories are Biotechnology Research
Contrafect Corp's founding year is 2008
